CoChat

A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

The DOI matches its Crossref record; 56 of the 59 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Obsessive-compulsive disorder (OCD) is a common debilitating psychiatric illness that typically improves but does not remit with first-line medication and behavioral treatments. Serotonergic agents including selective serotonin reuptake inhibitors and clomipramine have provided the mainstay of OCD medication management for decades. Combined dopamine/serotonergic agents such as atypical antipsychotics are presently the only OCD-augmenting strategies proven effective via randomized controlled trials. Despite increasing evidence for a pathogenic role of glutamate in OCD, no controlled trials of glutamatergic augmenting agents have been reported. METHODS: An intent-to-treat sample included 44 subjects receiving standard treatment at the McLean/Massachusetts General Hospital Intensive Residential Treatment (IRT) program, 22 of whom also received memantine augmentation. Admission, monthly and discharge measures of OCD, depression, and psychosocial functioning were collected by raters blinded to augmentation status. Matched controls were selected based on sex, initial OCD severity, psychosocial functioning, and timing of admission. The Clinical Global Improvement Scale captured global clinical change. RESULTS: Mean (SD) Yale-Brown Obsessive Compulsive Scale score decreases were 7.2 (6.4) among the cases and 4.6 (5.9) among the matched controls, reflecting mean clinical improvement among the cases (27.0% decrease) but not the controls (16.5% decrease). Mean (SD) depression severity score decreases were 5.8 (9.5) among the cases and 4.7 (9.9) among the controls. Initial intrusive obsessions were significantly more severe among marked responders compared with limited response or nonresponse cases (4.4 vs 2.9; t = 2.15; P = 0.048). CONCLUSIONS: This study provides preliminary supportive evidence for the effectiveness of memantine as a glutamatergic augmenting agent in severe OCD. Future randomized double-blind placebo-controlled trials are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e3181c856de

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Cited by

See all 159

Metadata

Authors
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A.
Affiliations
  • Harvard University (US)
  • McLean Hospital (US)
  • Tufts University (US)
Corresponding author
  • Stewart, S. Evelyn
  • Jenike, Eric A.
  • Hezel, Dianne M.
  • Stack, Denise Egan
  • Jenike, Michael A.
Venue
Journal of Clinical Psychopharmacology
Published
2010-02
Volume
30
Issue
1
Pages
34-39
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2056828397
Cited by
158
References
59
Citations by year
2026: 2 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 2 · 2019: 9 · 2018: 6 · 2017: 7 · 2016: 15 · 2015: 11 · 2014: 13 · 2013: 18 · 2012: 14
FWCI
21.38
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
memantine, obsessive-compulsive disorder, drug augmentation, depression severity, Yale-Brown Obsessive Compulsive Scale, treatment response
MeSH terms
Adult, Benzodiazepines, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Inpatients, Male, Memantine, Obsessive-Compulsive Disorder, Residential Facilities, Antipsychotic Agents, Case-Control Studies, Single-Blind Method, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Excitatory Amino Acid Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder. https://app.cochat.ai/papers/10.1097/jcp.0b013e3181c856de
The paper
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A. (2010). A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e3181c856de

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.